Acetic Acid

Acetic Acid

SCHEMBL8514161

CC(=O)O.OCCS

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL28002331 0.97 FFAR3 (0.47)
Acetone SCHEMBL27844742 0.89
Acetic Acid SCHEMBL15380491 0.85
Acetic Acid SCHEMBL743878 0.85 FFAR3 (0.58)
Methacrylic Acid SCHEMBL5072684 0.82 TDP1 (0.36)
Acetic Acid SCHEMBL7784606 0.81 FFAR3 (0.64)
Acetic Acid SCHEMBL1879030 0.81 FFAR3 (0.64)
Acetic Acid SCHEMBL17909908 0.81 FFAR3 (0.64)
Acetic Acid SCHEMBL2516097 0.81 FFAR3 (0.64)
Acetic Acid SCHEMBL1578192 0.81 FFAR3 (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012071288-A1 SEMICONDUCTOR INKS, FILMS, COATED SUBSTRATES AND METHODS OF PREPARATION E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-05-31 WO disclosed
EP-0201188-A2 5-Substituted pyrazolo[4,3-d] pyrimidine-7-ones, process for preparing the compounds and pharmaceutical compositions comprising the compounds WARNER-LAMBERT COMPANY (US) 1986-12-17 EP disclosed
US-4097502-A HYDROPHOBIC-HYDROPHILIC BALANCE LIPID SPECIALTIES, INC., A CORP. OF MA 1978-06-27 US disclosed